Ji L, Ahmann AJ, Ahren B, Capehorn MS, et al. Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once-weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1-5, 7-10 and SUSTAIN China. Diabetes Obes Metab 2023 Oct 12. doi: 10.1111/dom.15309.
PMID: 37822270